← Tra cứu cổ phiếu

iShareInvest Research

HNX · Quý 2/2026

CTB

Chế tạo Bơm Hải Dương

Analysis of business results & financial statements · Quý 2/2026

▼ Under pressure

Trailing net profit reached 45.5bn, fell 19.2bn compared with the same period last year. Key positives came from lower selling expenses, lower tax, and lower administrative expenses. Offsetting pressure came mainly from lower gross profit. Detailed impact is shown below:

See what is changing ↓
P/E
6.83x
P/B
1.09x
EPS
2,415
BVPS
15,092
ROE
14.9%
ROA
6.5%
Market price
16,500
16 Oct 2026

What Is Changing

On a TTM 2026Q2 basis, CTB is declining across multiple metrics versus the same period, suggesting current pressure is not coming from just one side. What remains unclear is whether the business can stabilize before this trend deepens.

Profit bridge

Vs last year · TTM

  1. Selling expenses
  2. Tax
  3. Administrative expenses
  4. Gross profit
Unit: VND bn. Green bars support profit; red bars reduce profit.

A single data point, or a trajectory?

Latest eight quarters · Quý 2/2026

MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue164.856.4265.590.1145.483.3453.898.9
LNST27.12.89.46.212.011.135.46.2
Net margin16.47%5.04%3.53%6.83%8.25%13.34%7.79%6.29%

Revenue

165bn

Net income

27bn

Net margin

16.47%

A closer look at what is happening inside the business

A company's statements are read with the questions that fit its type of business.

01

Is the profit sustainable?

Margins narrowed but earnings quality remains clean — pressure is mainly operational.

Revenue Growth

▼▼

Is growth real and durable?

Trailing-12-month revenue declined 26.2% year on year — not from a single spike: quarterly growth stepped up from −9% to +13%.

1 of the last 4 quarters grew year on year.

Revenue TTM
577bn
−26.2%
Latest quarter YoY
+13%
accelerating

What is driving the margin?

●

Net margin narrowed to 7.89%, falling 0.4pp. The main pressure is SG&A / Revenue rose 1.5pp, outweighing the improvement in Gross margin rose 1.6pp (with lingering pressure from Net financial result / Revenue fell 0.1pp).

The pressure comes from core operations — this is a concerning type of decline, not a one-off movement.

Net Margin
7.89%
−0.4pp
Gross Margin
21.91%
+1.6pp
SG&A / Revenue
11.64%
+1.5pp

TTM YoY · 2025Q2 -> 2026Q2

Cash Flow

▼

Is profit converting into cash?

With leverage safe, cash flow shows the self-funding capacity. Operating cash flow reached 93.9bn against investing cash flow of -57.6bn (annual cash-flow figures for 2025).

Post-investment cash flow was positive +36.2bn. Financing cash flow was negative +25.6bn.

CFO / net income was 2,74 lần.

After spending +39.5bn on fixed-asset investment, the business generated trailing free cash flow of +85.3bn.

Earnings Quality

▲

How much income is non-core?

About 98% of pre-tax profit comes from core operations.

Within that, net financial result at +2.0%, other profit at +0.3% of PBT.

Non-core / PBT
2.3%
low
Net financial / PBT
2.0%
Other profit / PBT
0.3%
02

Is capital being used efficiently?

Capital efficiency is declining — check whether the drag is from margins or turnover.

Is capital being deployed efficiently?

▼▼

ROIC fell to 14.78%, losing 5.9pp. That translates to 14.78 in after-tax operating profit for every 100 units of operating capital. Both NOPAT margin narrowed 0.3pp and capital turnover fell 0.65x, with invested capital holding roughly steady — pressure came from both operational efficiency and asset efficiency.

Pressure came from turnover — added capital has not been absorbed quickly enough, a typical investment-cycle dynamic.

Working Capital Efficiency

▼

Cash conversion cycle lengthened by 21.9 days versus the same period last year. The main moves came from DIO rose 43.9 days, DSO rose 11.3 days, and DPO rose 33.3 days.

Working capital cycle lengthened mainly due to slower inventory turnover — more capital is being tied up in inventory.

Cash conversion cycle remains stretched

CCC stands at 125.1 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +11.3 days, pointing to slower receivables turnover.

DuPont

What drives ROE?

Net margin 7.9% -0.4pp
Asset turnover 0.83x -0.40x
Financial leverage 2.27x +0.11x
ROE 14.9% -7.1pp

ROE fell from 22.0% to 14.9% — asset turnover weakened the most, though leverage still provided support.

03

Is financial risk significant?

Financial risk is low — leverage is safe, both CFO and FCF are positive.

Leverage & Liquidity

▲

Leverage looks fairly comfortable, with net debt / equity at 0.03x and interest coverage at 14.74x.

At present, short-term debt accounts for 100.0% of total debt, cash equals 65.0% of debt, and total debt stands at 27.1bn.

Net Debt / Equity
0.03x
−0.00x
Interest Coverage
14.74x
−16.30x
Cash / Debt
65.0%
−15.8pp
Short-term Debt / Total Debt
100.0%
0.0pp

TTM YoY · 2025Q2 -> 2026Q2

Short-term refinancing pressure is meaningful

Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.

Balance Sheet

●

The balance sheet shows capital-allocation efficiency slipping. Capital structure is conservative with low leverage — liabilities at 0.84x equity, net debt at 0.03x equity.

Inventory ended the period at 146.1bn, roughly 25.3% of total assets.

Over the last 12 months, working capital released 70.6bn of cash, mainly thanks to lower receivables. Pressure from higher inventories and lower payables only partly offset that benefit.

Research synthesis

What this reporting period is showing

The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is earnings conversion is confirmed, with CFO/NI at 2.74x. The main risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 125 days.

  • Improvement: earnings conversion looks more confirmed, with CFO / net income at 2.74x.
  • Key risk: working capital remains tied up for too long, with cash cycle at 125.1 days.

Questions for the next period

  1. Whether revenue stabilizes after a −26,2% YoY decline or keeps falling.

  2. Whether margins hold around the current 7.89% level or narrow again.

  3. Whether operating cash flow holds its 93.9bn (cumulative for 2025) level in upcoming periods or weakens.

From one stock to the whole portfolio

Where does this stock stand
among the rest of your investments?

Each stock is only one part of the wider picture. Looking at investments side by side makes their contribution, risks and opportunities across the portfolio clearer.

How much does this stock
contribute to the portfolio?

Its weight and influence across the assets held for investment.

Is the portfolio
well balanced?

How holdings, sectors and asset groups are distributed in relation to overall risk.

What other opportunities
or risks may be present?

What becomes visible only when investments are viewed together rather than one ticker at a time.

View my portfolio